Peter Kolchinsky

Affiliations

  • Large Shareholder, Director at Forma Therapeutics Holdings Inc. (FMTX), 2021-06-21
  • Large Shareholder, Director at Janux Therapeutics Inc. (JANX), 2021-06-16
  • Large Shareholder, Director at Werewolf Therapeutics Inc. (HOWL), 2021-06-16
  • Large Shareholder, Director at 89Bio Inc. (ETNB), 2021-06-04
  • Large Shareholder at Satsuma Pharmaceuticals Inc. (STSA), 2021-04-05
  • Large Shareholder at Vor Biopharma Inc. (VOR), 2021-04-05
  • Large Shareholder at Wave Life Sciences Ltd. (WVE), 2021-04-05
  • Large Shareholder, Director at Solid Biosciences Inc. (SLDB), 2021-04-05
  • Large Shareholder at Iteos Therapeutics Inc. (ITOS), 2021-04-05
  • Large Shareholder at Nkarta Inc. (NKTX), 2021-04-05
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2021-04-05
  • Chief Executive Officer at Research Alliance Corp. Ii (RACB), 2021-03-18
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2021-03-16
  • Large Shareholder at Phathom Pharmaceuticals Inc. (PHAT), 2021-03-15
  • Large Shareholder, Director at Orchard Therapeutics Plc (ORTX), 2021-02-11
  • Large Shareholder at Iterum Therapeutics Plc (ITRM), 2021-02-08
  • Large Shareholder at Miragen Therapeutics Inc. (MGEN), 2020-12-17
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2020-12-04
  • Large Shareholder at Vaxcyte Inc. (PCVX), 2020-10-09
  • Large Shareholder at Cardiff Oncology Inc. (CRDF), 2020-10-02
  • Large Shareholder at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
  • Large Shareholder at Dyne Therapeutics Inc. (DYN), 2020-09-23
  • Large Shareholder at Tg Therapeutics Inc. (TGTX), 2020-09-11
  • Large Shareholder at Inhibrx Inc. (INBX), 2020-08-24
  • Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-22
  • Chief Executive Officer at Therapeutics Acquisition Corp. (TXAC), 2020-07-08
  • Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
  • Large Shareholder at Verastem Inc. (VSTM), 2020-06-29
  • Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2020-04-03
  • Large Shareholder at Imara Inc. (IMRA), 2020-03-17
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2020-01-24
  • Director at Dicerna Pharmaceuticals Inc (DRNA), 2019-12-02
  • Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2018-10-25
  • Other at Arvinas Inc. (ARVN), 2018-10-03
  • Large Shareholder at Eidos Therapeutics Inc. (EIDX), 2018-06-22
  • Large Shareholder, Director at Kalvista Pharmaceuticals Inc. (KALV), 2017-10-16
  • Other at G1 Therapeutics Inc. (GTHX), 2017-05-24
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2016-09-19
  • Other at Sangamo Biosciences Inc (SGMO), 2015-02-19
  • Large Shareholder at Achillion Pharmaceuticals Inc (ACHN), 2015-01-20
  • Other at Derma Sciences Inc. (DSCI), 2014-01-13
  • Large Shareholder at Biospecifics Technologies Corp (BSTC), 2010-02-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FMTX $20.00 4,000,000 Large Shareholder, Director 9,011,651 2020-06-23 Filing
THOR $11.00 4,545,455 Large Shareholder, Director 9,724,598 2018-12-11 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DRNA $24.98 137,176 Director 0 2019-12-02 Filing
DRNA $24.22 138,000 Director 137,176 2019-11-29 Filing
DRNA $24.04 368,700 Director 275,176 2019-11-27 Filing
DRNA $23.59 239,700 Director 643,876 2019-11-26 Filing
DRNA $24.06 361,200 Director 883,576 2019-11-25 Filing